S. Munir Alam

Active 1996–2025

113
Papers
19,015
Citations
78
h-index
110
i10-index

Citations

Citations per year for S. Munir Alam1995: 1 citations1996: 7 citations1997: 20 citations1998: 19 citations1999: 23 citations2000: 23 citations2001: 24 citations2002: 16 citations2003: 24 citations2004: 21 citations2005: 38 citations2006: 61 citations2007: 66 citations2008: 57 citations2009: 74 citations2010: 71 citations2011: 110 citations2012: 166 citations2013: 322 citations2014: 318 citations2015: 286 citations2016: 306 citations2017: 350 citations2018: 300 citations2019: 783 citations2020: 726 citations2021: 712 citations2022: 554 citations2023: 339 citations2024: 610 citations2025: 271 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,381 citing papers, 44% of this breakdownUnited Kingdom: 368 citing papers, 6.8% of this breakdownChina: 315 citing papers, 5.8% of this breakdownFrance: 203 citing papers, 3.7% of this breakdownGermany: 200 citing papers, 3.7% of this breakdownCanada: 196 citing papers, 3.6% of this breakdownNetherlands: 175 citing papers, 3.2% of this breakdownSouth Africa: 160 citing papers, 3% of this breakdownSwitzerland: 149 citing papers, 2.8% of this breakdownAustralia: 124 citing papers, 2.3% of this breakdownItaly: 105 citing papers, 1.9% of this breakdownJapan: 76 citing papers, 1.4% of this breakdown
0%44%Other 17.8%

Fields

  • Immunology and Microbiology50.1%
  • Medicine33.8%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Agricultural and Biological Sciences1.1%
  • Neuroscience0.8%
  • Environmental Science0.4%
  • Other1.4%

Topics

  • HIV Research and Treatment12.9%
  • Immune Cell Function and Interaction9.6%
  • T-cell and B-cell Immunology8%
  • Monoclonal and Polyclonal Antibodies Research7.6%
  • SARS-CoV-2 and COVID-19 Research5.7%
  • Immunotherapy and Immune Responses5.1%
  • Other51.1%

Coauthors

All papers

Open in search
  1. Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael S. Seaman, Lawrence Shapiro, John R. Mascola, Peter D. Kwong, Mark Connors - Immunity 2016 cited by 395

  2. mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barton F. Haynes - Cell Reports 2022 cited by 80

  3. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Phillip W. Berman, Nicole Frahm, Stephen C. De Rosa, Michael D. Alpert, Nicole L. Yates, Xiaoying Shen, Richard A. Koup, Punnee Pitisuttithum, Jaranit Kaewkungwal, Sorachai Nitayaphan, Supachai Rerks‐Ngarm, Nelson L. Michael, Jérôme H. Kim - New England Journal of Medicine 2012 cited by 1,834

  4. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura L. Sutherland, David C. Montefiori, Robert J. Edwards, Kevin O. Saunders, Charlene McDanal, Giovanna E. Hernandez, Katayoun Mansouri, Robert E. Parks, Xiaozhi Lu, Blake M. Hauser, C. Todd DeMarco, Fangping Cai, Barney S. Graham, Kevin Wiehe, John R. Mascola, Gregory D. Sempowski, Hanné Andersen, Elizabeth Petzold, David R. Martinez, Peter D. Kwong, Victoria Gee-Lai, Megan Kopp, S. Gobeil, Victoria Stalls, Aja Sanzone, Wes Rountree, Barton F. Haynes, Mark G. Lewis, Priyamvada Acharya, Thomas H. Oguin, Chuancang Jiang, I‐Ting Teng, Andrew Foulger, Christopher W. Woods - Cell 2021 cited by 334

  5. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cathy Masiello, Baishali Maskeri, Jenny McDowell, Casandra Montemayor, James C. Mullikin, Morgan Park, Nancy Riebow, Karen Schandler, Brian Schmidt, Christina Sison, Mal Stantripop, James Thomas, Pam Thomas, Meg Vemulapalli, Alice Young, James C. Mullikin, S. Gnanakaran, Peter Hraber, Kevin Wiehe, Garnett Kelsoe, Guang Yang, Shi-Mao Xia, David C. Montefiori, Robert E. Parks, Krissey E. Lloyd, Richard M. Scearce, Kelly A. Soderberg, Myron S. Cohen, Gift Kamanga, Mark K. Louder, Lillian Tran, Yue Chen, Fangping Cai, Sheri Chen, Stephanie Moquin, Xiulian Du, M. Gordon Joyce, Sanjay Srivatsan, Baoshan Zhang, Anqi Zheng, George M. Shaw, Beatrice H. Hahn, Thomas B. Kepler, Bette Korber, Peter D. Kwong, John R. Mascola, B F Haynes - Nature 2013 cited by 1,061

  6. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas H. Oguin, Gregory D. Sempowski, Matthew Gagné, Daniel C. Douek, Mark A. Tomai, Christopher B. Fox, Robert A. Seder, Kevin Wiehe, Drew Weissman, Norbert Pardi, Hana Golding, Surender Khurana, Priyamvada Acharya, Hanné Andersen, Mark G. Lewis, Ian N. Moore, David C. Montefiori, Ralph S. Baric, Barton F. Haynes - Nature 2021 cited by 276

  7. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 852

  8. 3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Immunology 2020 cited by 151

  9. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Derek W. Cain, Mattia Bonsignori, David C. Montefiori, Frederick W. Alt, Barton F. Haynes - Science 2019 cited by 184

  10. Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David C. Montefiori, Ashley M. Trama, Hua‐Xin Liao, Thomas B. Kepler, M. Anthony Moody, Feng Gao, Samuel J. Danishefsky, John R. Mascola, George M. Shaw, Beatrice H. Hahn, Stephen C. Harrison, Bette Korber, Barton F. Haynes - Science Translational Medicine 2017 cited by 290

  11. Envelope residue 375 substitutions in simian–human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert W. Doms, David C. Montefiori, Barton F. Haynes, Joseph Sodroski, Peter D. Kwong, Beatrice H. Hahn, George M. Shaw - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 239

  12. Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development

    Authors: , , , , , , , , , , , - Cell Host & Microbe 2018 cited by 148

  13. Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brenna J. Hill, Rui Kong, Cinque Soto, James C. Mullikin, Daniel C. Douek, David C. Montefiori, Michael A. Moody, George M. Shaw, Beatrice H. Hahn, Garnett Kelsoe, Peter Hraber, Bette Korber, Scott D. Boyd, Andrew Fire, Thomas B. Kepler, Lawrence Shapiro, Andrew B. Ward, John R. Mascola, Hua‐Xin Liao, Peter D. Kwong, Barton F. Haynes - Cell 2016 cited by 341

  14. Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

    Authors: , , , , , , , , , , , , - Science 2005 cited by 752

  15. Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georgia D. Tomaras - Science Translational Medicine 2014 cited by 454

  16. A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kevin O. Saunders, Priyamvada Acharya, Barton F. Haynes, Ralph S. Baric - Science Translational Medicine 2021 cited by 139

  17. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas H. Oguin, Gregory D. Sempowski, Mattia Bonsignori, Celia C. LaBranche, David C. Montefiori, Michael S. Seaman, Sampa Santra, John R. Perfect, Joseph R. Francica, Geoffrey M. Lynn, Baptiste Aussedat, William E. Walkowicz, Richard Laga, Garnett Kelsoe, Kevin O. Saunders, Daniela Fera, Peter D. Kwong, Robert A. Seder, Alberto Bartesaghi, George M. Shaw, Priyamvada Acharya, Barton F. Haynes - Cell 2021 cited by 91

  18. Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L. Escudero Méndez, M. Anthony Moody, Anne Marie O’Sullivan, Christopher L. Owen, Dongjun Peng, Reda Rawi, Eric Sanders‐Buell, Chen‐Hsiang Shen, Andrea R. Shiakolas, Tyler Stephens, Yaroslav Tsybovsky, Courtney Tucker, Raffaello Verardi, Keyun Wang, Jing Zhou, Tongqing Zhou, George Georgiou, S. Munir Alam, Barton F. Haynes, Morgane Rolland, Gary R. Matyas, Victoria R. Polonis, Adrian B. McDermott, Daniel C. Douek, Lawrence Shapiro, Sodsai Tovanabutra, Nelson L. Michael, John R. Mascola, Merlin L. Robb, Peter D. Kwong, Nicole A. Doria‐Rose - Immunity 2019 cited by 119

  19. Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Anthony Moody, Derek W. Cain, Ying K. Tam, Mark G. Lewis, Wilton B. Williams, Kevin Wiehe, David C. Montefiori, Priyamvada Acharya, Barton F. Haynes - Cell 2024 cited by 57

  20. A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2022 cited by 41

  21. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2019 cited by 85

  22. Stabilized HIV-1 envelope immunization induces neutralizing antibodies to the CD4bs and protects macaques against mucosal infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Priyamvada Acharya, Barton F. Haynes - Science Translational Medicine 2022 cited by 39

  23. Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Georgia D. Tomaras, S. Munir Alam, Hua-Xin Liao, Barton F. Haynes - Journal of Virology 2011 cited by 439

  24. Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2014 cited by 293